Company profile: GeneDx
1.1 - Company Overview
Company description
- Provider of genomic diagnostics and data science solutions using artificial intelligence and machine learning to deliver personalized, actionable insights that improve health outcomes. Offers XomeDxXpress rapid whole exome sequencing (provisional results in 7 days, full report in 2 weeks), whole genome sequencing with optional trio testing, and genetic counseling services for patients and healthcare providers.
Products and services
- Whole Genome Sequencing: Delivers comprehensive genomic insights with trio-enabled testing to improve data interpretation and diagnosis speed across the entire genome
- XomeDxXpress: A rapid-turnaround whole exome sequencing test for critically ill patients, delivering provisional results in 7 days and full report in 2 weeks
- Genetic Counseling Services: Patient-centered counseling for both patients and healthcare providers, facilitating patient care across GeneDx’s personalized, actionable insights approach
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to GeneDx
OralDNA Labs
HQ: United States
Website
- Description: Provider of salivary diagnostics services to treat, heal, and inspire oral health, offering a wide range of tests including DNA polymerase chain reaction (PCR) and next-generation sequencing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OralDNA Labs company profile →
Provista Diagnostics
HQ: United States
Website
- Description: Provider of blood-based diagnostic tests focused on oncology, including Videssa Breast Cancer Test combining serum protein biomarkers and tumor-associated autoantibodies for high-accuracy detection in women with abnormal imaging findings. Also offers COVID-19 PCR testing with same-day results from car-based collection, Long COVID panel, FDA-EUA real-time qPCR respiratory tests, UTI PCR testing, and wound infection testing with antibiotic resistance assessment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Provista Diagnostics company profile →
Mitotyping Technologies
HQ: United States
Website
- Description: Provider of forensic DNA analysis services for the criminal justice system, forensic laboratories, and anthropological applications, including mitochondrial DNA testing from small samples such as 2mm hair fragments or single teeth.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mitotyping Technologies company profile →
Purigen Biosystems
HQ: United States
Website
- Description: Provider of automated solutions for DNA and RNA purification using a proprietary approach with isotachophoresis to separate nucleic acids freely in solution without binding or stripping from a physical surface; technology is agnostic to nucleic acid size or sequence.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Purigen Biosystems company profile →
Cepheid
HQ: United States
Website
- Description: Provider of accurate, easy-to-use molecular diagnostic systems and tests that automate complex procedures for institutions of any size. Offerings include the GeneXpert System and single-use Xpert cartridges for nucleic acid extraction, amplification, and detection, plus Xpert Xpress PCR tests for Strep A, SARS-CoV-2, CoV-2/Flu/RSV, and Flu A/B.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cepheid company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for GeneDx
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to GeneDx
2.2 - Growth funds investing in similar companies to GeneDx
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for GeneDx
4.2 - Public trading comparable groups for GeneDx
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →